Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trial

Title: Efficacy and safety of switching to long-acting cabotegravir + rilpivirine versus continuing bictegravir/emtricitabine/tenofovir alafenamide in Japanese participants: 12-month results from the phase 3b randomized SOLAR trial
Authors: Adachi, Eisuke; Yokomaku, Yoshiyuki; Watanabe, Dai; Gatanaga, Hiroyuki; Oka, Shinichi; Shirasaka, Takuma; Wakatabe, Rumi; Chamay, Nadine; Sutton, Kenneth; Sutherland-Phillips, Denise; Urbaityte, Rimgaile; D'Amico, Ronald; van Wyk, Jean
Contributors: ViiV Healthcare
Source: Journal of Infection and Chemotherapy ; volume 31, issue 7, page 102734 ; ISSN 1341-321X
Publisher Information: Elsevier BV
Publication Year: 2025
Collection: ScienceDirect (Elsevier - Open Access Articles via Crossref)
Document Type: article in journal/newspaper
Language: English
DOI: 10.1016/j.jiac.2025.102734
Availability: https://doi.org/10.1016/j.jiac.2025.102734; https://api.elsevier.com/content/article/PII:S1341321X2500131X?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S1341321X2500131X?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number: edsbas.3F11C921
Database: BASE